| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 179.52 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Introdução: a infeção por SARS-CoV-2 veio modificar os cuidados de saúde, levando a que técnicas inovadoras de administração de oxigénio fossem testadas. A Oxigenoterapia nasal de alto fluxo (ONAF) ganhou destaque nesta pandemia, tornando-se, muitas vezes, controversa na abordagem ao doente com COVID-19. Objetivos: o objetivo desta scoping review é mapear a evidência disponível sobre os benefícios do uso da ONAF no doente com infeção por SARS-CoV-2. Materiais e métodos: a presente scoping review será guiada segundo a metodologia do Joanna Briggs Institute. Foram definidos critérios de elegibilidade com base na população, conceito e contexto, considerando adultos com infeção por SARS-CoV-2 (população), oxigenoterapia nasal de alto fluxo (conceito), contexto hospitalar (contexto). Considerou-se bibliografia publicada e não publicada em português, inglês e espanhol, sendo limitada para publicações do ano 2020, nas bases de dados MEDLINE complete, CINAHL complete, PubMed, Cochrane, Nursing & Allied Health Collection e ainda OpenGrey e RCAAP. Dois revisores independentes triaram os títulos e resumos e posteriormente analisaram o texto completo dos documentos selecionados, extraindo a informação útil. Resultados: pela pesquisa em bases de dados encontraram-se 119 artigos, tendo sido apenas incluídos 12 na scoping review. Na generalidade, todos os estudos apresentam benefícios acerca da utilização da ONAF na pessoa com infeção por SARS-CoV-2, nomeadamente na redução da taxa de ventilação mecânica, na redução do tempo de internamento, uma melhor tolerância da técnica, bem como mais conforto, comparativamente a outras terapias de administração de oxigénio. Considera-se que o risco de contaminação por aerossolização é reduzido, caso sejam garantidas as devidas medidas de segurança. Conclusões: a ONAF é considerada uma técnica segura e com benefícios na abordagem ao doente com infeção por SARS-CoV-2. Ressalvamos que os enfermeiros têm um papel fundamental na vigilância e segurança da pessoa submetida à ONAF.
Introduction: the SARS-CoV-2 infection has come to change medical health care by pressing for the testing of innovative oxygen administration technics. The high flow nasal cannula therapy (HFNC) stood out in this pandemic, as rather conflicting approaches were taken when caring for COVID-19 patients. Objectives: the purpose of this scoping review is to map available data on the benefits of HFNC in patients with SARS-CoV-2 infection. Material and methods: this scoping review will have Joanna Briggs Institute methodology as guidance. Some criteria of eligibility were taken into consideration to define the population, concept and context, taking into account adults with SARS-CoV-2 (population), high flow nasal cannula (concept) and hospital setting (context). Literature published and not publish in Portuguese, English and Spanish was reviewed, specifically from the year of 2020, and from the following databases: MEDLINE complete, CINAHL complete, PubMed, Cochrane, Nursing & Allied Health Collection and OpenGrey and RCAAP. Two independent reviewers screened the titles and summaries, and latter analysed the complete text of the selected documents, using the relevant information. Results: during the course of this search, 119 articles were found of which 12 were included in this scoping review. In general, all studies presented evidences of the benefits of high flow nasal cannula therapy when caring for patients with SARS-CoV-2 infections, as the reduction of the rate of mechanical ventilation; time of hospital stay; better tolerance of the technic as well as better comfort when compared to other oxygen administration technics. Risk in aerosolization was considered to be reduced provided that specific security measurements are secured. Conclusions: the HFNC in considered to be a secure technic with specific benefits in the care of the SARS-CoV-2 infected patient. We note that nurses have a rather crucial role in the supervision and safety of the HFNC patient.
Introduction: the SARS-CoV-2 infection has come to change medical health care by pressing for the testing of innovative oxygen administration technics. The high flow nasal cannula therapy (HFNC) stood out in this pandemic, as rather conflicting approaches were taken when caring for COVID-19 patients. Objectives: the purpose of this scoping review is to map available data on the benefits of HFNC in patients with SARS-CoV-2 infection. Material and methods: this scoping review will have Joanna Briggs Institute methodology as guidance. Some criteria of eligibility were taken into consideration to define the population, concept and context, taking into account adults with SARS-CoV-2 (population), high flow nasal cannula (concept) and hospital setting (context). Literature published and not publish in Portuguese, English and Spanish was reviewed, specifically from the year of 2020, and from the following databases: MEDLINE complete, CINAHL complete, PubMed, Cochrane, Nursing & Allied Health Collection and OpenGrey and RCAAP. Two independent reviewers screened the titles and summaries, and latter analysed the complete text of the selected documents, using the relevant information. Results: during the course of this search, 119 articles were found of which 12 were included in this scoping review. In general, all studies presented evidences of the benefits of high flow nasal cannula therapy when caring for patients with SARS-CoV-2 infections, as the reduction of the rate of mechanical ventilation; time of hospital stay; better tolerance of the technic as well as better comfort when compared to other oxygen administration technics. Risk in aerosolization was considered to be reduced provided that specific security measurements are secured. Conclusions: the HFNC in considered to be a secure technic with specific benefits in the care of the SARS-CoV-2 infected patient. We note that nurses have a rather crucial role in the supervision and safety of the HFNC patient.
Description
Keywords
Oxigenoterapia Infeção Insuficiência respiratória Cuidados de enfermagem SARS-CoV-2 Oxygen inhalation therapy Infection Respiratory failure Nursing care